CLSA Board Engages Lawmakers in Washington D.C. During Capitol Hill Advocacy Day
May 25, 2018
By Adam Lotspike
On May 23, 15 members of CLSA’s Board of Directors spent a full day on Capitol Hill meeting with nearly 2 dozen key legislators and senior staff on issues of importance to California’s biomedical innovation ecosystem.
Meetings included: House Majority Leader Kevin McCarthy (R-Bakersfield), Reps. Nanette Barragán (D-Carson), Salud Carbajal (D-Santa Barbara), Tony Cárdenas (D-San Fernando Valley), Lou Correa (D-Santa Ana), Susan Davis (D-San Diego), Jimmy Gomez (D-Los Angeles), Jared Huffman (D-San Rafael), Jimmy Panetta (D-Monterey), Jackie Speier (D-San Mateo/South San Francisco), Eric Swalwell (D-East Bay), David Valadao (R-Hanford), and Mimi Walters (R-Irvine). In addition, we convened a roundtable discussion with members of the New Democrat Coalition, including: Tony Cárdenas (D-San Fernando Valley), Lou Correa (D-Santa Ana), Susan Davis (D-San Diego), Scott Peters (D-San Diego), Raul Ruiz, MD (D-Palm Desert) and Norma Torres (D-Pomona), and senior staff for Reps. Ami Bera, MD (D-Sacramento) and Julia Brownley (D-Thousand Oaks).
CLSA’s board members discussed issues including: how public and private insurers can better value medical innovation through coverage and payment policies; the importance of a patent system that preserves the ability for biomedical innovators to enforce their patents; our support for predictable and sustained NIH funding for basic research; the importance of a transparent and predictable FDA regulatory environment, including corresponding payment transparency and predictability for novel technologies.